高级检索
当前位置: 首页 > 详情页

Needle-free injection of insulin powder: delivery efficiency and skin irritation assessment

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C

单位: [1]Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu 610000, Peoples R China [2]302 Mil Hosp, China Mil Inst Chinese Med, Beijing 100039, Peoples R China [3]Capital Med Univ, Dept Tradit Chinese Med, Beijing Friendship Hosp, Beijing 100050, Peoples R China [4]302 Mil Hosp, Integrat Med Ctr, Beijing 100039, Peoples R China [5]Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China [6]Hunan Univ Tradit Chinese Med, Sch Pharm, Changsha 410208, Hunan, Peoples R China
出处:
ISSN:

关键词: Powder needleless injection Insulin Transdermal drug delivery Skin irritation

摘要:
Insulin is widely used in treating diabetes, but still needs to be administered by needle injection. This study investigated a new needle-free approach for insulin delivery. A portable powder needleless injection (PNI) device with an automatic mechanical unit was designed. Its efficiency in delivering insulin was evaluated in alloxan-induced diabetic rabbits. The skin irritation caused by the device was investigated and the results were analyzed in relation to aerodynamic parameters. Inorganic salt-carried insulin powders had hypoglycemic effects, while raw insulin powders were not effective when delivered by PNI, indicating that salt carriers play an important role in the delivery of insulin via PNI. The relative delivery efficiency of phosphate-carried insulin powder using the PNI device was 72.25%. A safety assessment test showed that three key factors (gas pressure, cylinder volume, and nozzle distance) were related to the amount of skin irritation caused by the PNI device. Optimized injection conditions caused minimal skin lesions and are safe to use in practice. The results suggest that PNI has promising prospects as a novel technology for delivering insulin and other biological drugs.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 生物
小类 | 4 区 生化与分子生物学 4 区 生物工程与应用微生物 4 区 医学:研究与实验
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 生物工程与应用微生物 2 区 医学:研究与实验
JCR分区:
出版当年[2012]版:
Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2012版] 出版当年五年平均[2008-2012] 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu 610000, Peoples R China [2]302 Mil Hosp, China Mil Inst Chinese Med, Beijing 100039, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)